Cargando…
Serum Calreticulin Is a Negative Biomarker in Patients with Alzheimer’s Disease
Calreticulin is down-regulated in the cortical neurons of patients with Alzheimer’s disease (AD) and may be a potential biomarker for the diagnosis of AD. A total of 128 AD patients were randomly recruited from May 2012 to July 2013. The mRNA levels of calreticulin were measured from the serum of te...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284675/ https://www.ncbi.nlm.nih.gov/pubmed/25429433 http://dx.doi.org/10.3390/ijms151221740 |